nifedipine has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calder, L; Clikeman, J; Finnegan, KT; Karler, R; Wei, S | 1 |
Docherty, JR; Lavelle, A; Leong, S; Rajamani, K | 1 |
2 other study(ies) available for nifedipine and n-methyl-3,4-methylenedioxyamphetamine
Article | Year |
---|---|
Effects of L-type calcium channel antagonists on the serotonin-depleting actions of MDMA in rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Chemistry; Calcium Channel Blockers; Cerebral Cortex; Flunarizine; Haloperidol; Hippocampus; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nifedipine; Rats; Rats, Sprague-Dawley; Seizures; Serotonin; Stereotyped Behavior; Verapamil | 1993 |
Prejunctional actions of methylenedioxymethamphetamine in vas deferens from wild-type and alpha(2A/D)-adrenoceptor knockout mice.
Topics: Adrenergic Agents; Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Animals; Desipramine; Dose-Response Relationship, Drug; Electric Stimulation; Female; Genotype; Heart Atria; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Contraction; N-Methyl-3,4-methylenedioxyamphetamine; Neuromuscular Junction; Nifedipine; Norepinephrine; Oxymetazoline; Receptors, Adrenergic, alpha-2; Tritium; Vas Deferens; Vasodilator Agents; Xylazine | 2001 |